Neuroscience tech developer ElectroCore said today it launched its gammaCore non-invasive vagus nerve stimulator, designed for the acute treatment of pain associated with episodic cluster headaches in adult patients, in the US.
The Basking Ridge, N.J.-based company touted the device as the 1st non-invasive, hand-held vagus nerve stimulation device for the reduction of pain. The system is designed to be applied to the neck and applies a patented electrical stimulation through the skin to activate the vagus nerve.
“We are proud to bring gammaCore to the U.S. market, as it provides episodic cluster headache sufferers with a much-needed treatment option for this rare and often debilitating condition. The commercial launch also signifies an important milestone for electroCore, marking the 1st marketed product for the company in the U.S.,” CEO Francis Amato said in a press release.
The device won FDA approval in April, and has also won CE Mark approval in the European Union, the company said.
Late last month, MassDevice.com spoke to ElectroCore CEO Amato about the gammaCore device, its slated launch in the US and how the device differs from other VNS therapy systems
Registration is open for DeviceTalks Boston! Join us on June 5-6, 2019, as we explore the trends and technology that are shaping the future of the medical device industry.